trending Market Intelligence /marketintelligence/en/news-insights/trending/jLc7icy37HUX_UVP7rGoEQ2 content esgSubNav
In This List

Aralez CFO departs; interim CFO named

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Aralez CFO departs; interim CFO named

Scott Charles is leaving Aralez Pharmaceuticals Inc. as CFO to pursue other opportunities, effective Nov. 30.

Michael Kaseta will assume the role of interim CFO along with his current duties as corporate controller, a role he has held since 2016.